首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Expansion of regulatory CD8+CD25+ T cells after neonatal alloimmunization
【2h】

Expansion of regulatory CD8+CD25+ T cells after neonatal alloimmunization

机译:新生儿同种免疫后调节性CD8 + CD25 + T细胞的扩增

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transplantation tolerance induced by neonatal injection of semi-allogeneic spleen cells is associated with a pathological syndrome caused by T helper type 2 (Th2) differentiation of donor-specific CD4+ T lymphocytes. We have shown previously that this Th2-biased response is inhibited by host CD8+ T cells. Herein, we demonstrate that upon neonatal immunization with (A/J × BALB/c)F1 spleen cells, BALB/c mice expand a population of CD8+ T cells expressing both CD25 and forkhead box P3 (FoxP3) markers. In this setting, CD8+CD25+ T cells predominantly produce interferon (IFN)-γ and interleukin (IL)-10 and are efficient in controlling IL-4, IL-5 and IL-13 production by donor-specific CD4+ T cells in vitro. CD8+FoxP3- T cells are single producers of IFN-γ or IL-10, whereas CD8+FoxP3+ T cells are double producers of IFN-γ and IL-10. We further demonstrate that IFN-γ and IL-10 are two major cytokines produced by CD8+ T cells involved in the in vivo regulation of Th2-type pathology. In this setting, we conclude that neonatal alloimmunization induces the expansion of several regulatory CD8+ T cells which may control Th2 activities via IFN-γ and IL-10.
机译:新生儿注射半同种异型脾细胞诱导的移植耐受性与供体特异性CD4 + T淋巴细胞的T辅助2型(Th2)分化引起的病理综合征有关。先前我们已经表明,这种由Th2引起的应答被宿主CD8 + T细胞抑制。在本文中,我们证明了在用(A / J×BALB / c)F1脾细胞进行新生儿免疫后,BALB / c小鼠扩大了表达CD25和叉头盒P3(FoxP3)的CD8 + T细胞的种群)标记。在这种情况下,CD8 + CD25 + T细胞主要产生干扰素(IFN)-γ和白介素(IL)-10,并有效控制IL-4,IL-供体特异性CD4 + T细胞体外分泌5和IL-13。 CD8 + FoxP3 - T细胞是IFN-γ或IL-10的单一产生者,而CD8 + FoxP3 + T细胞是IFN-γ和IL-10的双重产生者。我们进一步证明IFN-γ和IL-10是参与Th2型病理体内调节的CD8 + T细胞产生的两种主要细胞因子。在这种情况下,我们得出结论,新生儿同种免疫会诱导几种调节性CD8 + T细胞的扩增,这些CD8 + T细胞可能通过IFN-γ和IL-10控制Th2的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号